ProbioMed Women 30c by Designs for Health
ProbioMed™ Women represents a daily probiotic formulation intricately designed to address and bolster women's health, specifically targeting the intricate ecosystems of the vaginal and gastrointestinal (GI) tracts.* This scientifically crafted formula delivers a clinically significant dosage of 25 billion colony-forming units (CFUs), encompassing ten meticulously researched probiotic strains recognized for their efficacy in fostering microbial equilibrium within the vaginal and GI environments.*
The probiotic strains in ProbioMed™ Women play a vital role in supporting a balanced microbial milieu in both the vaginal and GI tracts, contributing to the maintenance of a healthy and harmonious microbial community. This targeted approach extends further to promote a normative vaginal pH, a robust immune response, and the integrity of the gut-brain axis—highlighting the multifaceted benefits of this formulation.
Notably, ProbioMed™ Women stands out in the market due to its concentration of probiotic strains, each selected for its researched efficacy in addressing specific aspects of women's health. The comprehensive blend aims to cater to the nuanced microbial requirements of the vaginal and GI tracts, promoting a state of equilibrium that is conducive to overall well-being.
The distinctive feature of delayed-release technology in the encapsulation of these probiotic strains is a noteworthy aspect of ProbioMed™ Women. This technology ensures optimal survival of the probiotics through the stomach's acidic environment and facilitates their timed release in the lower GI tract. This innovative approach enhances the probiotics' viability, allowing them to reach and exert their beneficial effects in the targeted regions of the digestive system.
In summary, ProbioMed™ Women emerges as a scientifically formulated probiotic supplement tailored to enhance women's health by targeting the vaginal and GI ecosystems.* Its unique blend of probiotic strains, delivering 25 billion CFUs, sets it apart in the market, addressing microbial balance, vaginal pH, immune response, and the gut-brain axis. The utilization of delayed-release technology further underscores its commitment to providing optimal probiotic efficacy throughout the digestive journey, making it a comprehensive and advanced solution for women's health.
Astarte™ Cultures 5 billion CFU / **
Lactobacillus crispatus (LBV88)
Lactobacillus rhamnosus (LBV96)
Lactobacillus gasseri (LBV150N)
Lactobacillus jensenii (LBV116)
Lactobacillus acidophilus (DDS®-1) 10 billion CFU / **
Lactobacillus plantarum (UALp-05™) 4 billion CFU / **
Lactobacillus paracasei (UALpc-04™) 2 billion CFU / **
Bifidobacterium bifidum (UABb-10™) 1 billion CFU / **
Bifidobacterium longum (UABl-14™) 1 billion CFU / **
Bifidobacterium lactis (UABla-12™) 2 billion CFU / **